Riskpilot← Back to searchSign inGet full accessBIOZIN AS
ASActiveOrg 915065074Gamle Ravei 321, 3270 LarvikManufacture of other chemical products n.e.c. · NACE 2059Est. 20150 employeeswww.biozin.no
Revenue 2024
NOK 0
EBITDA margin
—
-21% vs 2023
Equity ratio
74.9%
Financial strength
Net profit 2024
NOK -211K
+96% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -75K | -21% |
| Net profit | NOK -211K | +96% |
| Total assets | NOK 44,5M | -31% |
| Equity | NOK 33,3M | -1% |
| Employees | 0 | — |
Legal name
BIOZIN AS
Org number
915065074
Legal form
Aksjeselskap
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
23. mars 2015
Share capital
NOK 7 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikle teknologi i forbindelse med bio-energi produksjon, å eie og drive anlegg i forbindelse med slik produksjon, å fungere som en rådgiver, systemintegrerer og investor i selskaper som driver slik produksjon, og delta i virksomhet som står naturlig i denne forbindelse.
Address
Gamle Ravei 321, 3270 Larvik
Website
www.biozin.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 90 | 164 | 1 823 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −362 | −2 939 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −92 | −2 116 | −3 210 | −250 | −60 | −47 | −47 | −91 | −62 | −75 |
| Depreciation & amort. | −0 | −0 | −10 | −10 | −10 | −6 | −0 | −0 | −0 | −0 |
| EBIT | −92 | −2 116 | −3 220 | −260 | −70 | −53 | −47 | −91 | −62 | −75 |
| Net financials | 0 | 2 | −131 | −433 | −410 | −329 | −368 | −134 | −318 | −196 |
| Profit before tax | −92 | −2 114 | −3 350 | −693 | −480 | −381 | −415 | −225 | −380 | −271 |
| Tax | −0 | −528 | −748 | −159 | −106 | −84 | −91 | −49 | 5 493 | −60 |
| Net profit | −92 | −1 586 | −2 602 | −533 | −374 | −298 | −324 | −175 | −5 874 | −211 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 108 | 7 151 | 22 720 | 16 730 | 18 136 | 17 555 | 70 423 | 43 684 | 64 364 | 44 526 |
| Equity | −62 | 5 522 | 7 193 | 7 191 | 7 187 | 7 192 | 21 379 | 21 379 | 33 541 | 33 330 |
| Long-term debt | 75 | 0 | 15 000 | 9 451 | 10 761 | 10 286 | 14 254 | 4 798 | 4 891 | 1 187 |
| Short-term debt | 94 | 1 628 | 527 | 88 | 187 | 77 | 34 790 | 17 508 | 25 932 | 10 009 |
| Total debt | 169 | 1 628 | 15 527 | 9 539 | 10 948 | 10 363 | 49 044 | 22 306 | 30 823 | 11 196 |
EBITDA margin
-7484500.0%
This company
15.8%
Market median
-47370353% vs market
20152024
Equity ratio
74.9%
This company
38.2%
Market median
+96% vs market
20152024
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
20152024
Net profit margin
-21130500.0%
This company
8.1%
Market median
-260870470% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-02-05 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TS Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
MR Contact Person | Contact Person | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bergene Holm As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Løvenskiold-Vækerø As
BIOZIN AS Board members of BIOZIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Skadal | Chief Executive Officer | 0 companies |
| Morten Riis-Gjertsen | Contact Person | 0 companies |
| Paul Brede Fløholm | Board of Directors | 0 companies |
| Morten Floberg Evensen | Board of Directors | 0 companies |
| Erland Løkken | Chairman | 0 companies |